Aims In this study, we analyze the challenges involved in detecting novel neuraminidase inhibitors (NAIs) and offer strategies to overcome them with complementary bioassays. Materials & Methods We ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window With avian ...

Dr. Greg Poland answers the question: 'What AreTamiflu And Relenza?' May 27, 2009 -- Question:What are Tamiflu and Relenza? Answer:There are two different antiviral medications that can be used to ...

Please provide your email address to receive an email when new articles are posted on . Since May 2023, a combination of neuraminidase mutations has been detected in influenza A(H1N1)pdm09 viruses.

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and mortality. Current antiviral therapies, such as neuraminidase inhibitors and ...

Human parainfluenza viruses are a major cause of respiratory infections that particularly affect young children and immunocompromised individuals. These viruses present a significant global health ...

To date, tests of isolates from eight farms in Canada have yielded a rare neuraminidase (NA) protein mutation known as H275Y that has shown resistance to oseltamivir, according to a new research ...